Michael J. Fox Foundation Meeting Summary
We want to thank those members of our community who contacted the MJFF regarding the rejection of our grant application. Your outreach plus other contacts catalyzed a meeting with the Foundation last week. And it was a productive meeting.
The Foundation’s scientific leadership, General Counsel and VP of Communications engaged with us in a very collaborative way – discussing science, the RB-190 development plan and the design of the Phase 2A clinical trial.
We were encouraged to re-submit our application with some additional details around these topics. We are confident that they now understand more completely the science and our capability to successfully execute the clinical trial and advance RB-190 to market if it is successful in the trials.
You put us in a position for deeper and hopefully a more supportive relationship with the Foundation. We are very grateful and thank you for your support.
Share This
|
Sign up at: ParkinsonsDisease.blog |
About Jonathan Sackner-Bernstein, MD
Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD.
Dr. S-B’s Linkedin page
RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.